• Software
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • NAMVantage™
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
  • Search
Simulations Plus logo
Simulations Plus logo

Simulations Plus

We Improve Health Through Innovative Solutions

  • Software
      • GastroPlus®
      • MonolixSuite™
      • ADMET Predictor®
      • DILIsym®
      • DDDPlus™
      • NAFLDsym®
      • MembranePlus™
      • Monolix®
      • OBESITYsym™
      • PKanalix®
      • Simulx®
      • IPFsym®
      • ILDsym®
      • RENAsym®
      • Pro-ficiency
      • Panorama KOL Insights Engine
      • MedChem Designer™
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Quantitative Systems Pharmacology (QSP)
      • Physiologically Based Pharmacokinetic (PBPK) Software
      • Cheminformatics
      • Adaptive Learning Insights (ALI)
      • Medical Communications
      • Software Packages
        • Consult + Coach
        • Plug ‘n’ Play
        • Pulmonary Package
        • First-in-Human Simulator
        • EvolvePK+
        • Liver Safety+
        • NAMVantage™
      • University+
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • NAMVantage™
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2017
View More
Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2017
  • March 13, 2017
  • Press Release

Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2017

Keywords: preliminary revenues
Division: PBPK
  • Read More
Simulations Plus Reports First Quarter FY2017 Financial Results
  • January 26, 2017
  • Press Release

Simulations Plus Reports First Quarter FY2017 Financial Results

Keywords: financial results, gross profit, net revenues
Division: PBPK

Consolidated net earnings up 23.1% on 12% revenue increase

  • Read More
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
  • January 20, 2017
  • Press Release

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share

Keywords: quarterly cash dividend
Division: PBPK
  • Read More
Simulations Plus Releases ADMET Predictor™ Version 8.1
  • January 12, 2017
  • Press Release

Simulations Plus Releases ADMET Predictor™ Version 8.1

Keywords: drug design, drug discovery, integration with MedChem Studio, molecular property prediction software, toxicity models
Software: ADMET Predictor®
Division: PBPK

Update streamlines key processes to efficiently handle large data sets

  • Read More
Simulations Plus Sets Date for 1st Quarter 2017 Earnings Release and Conference Call
  • January 4, 2017
  • Press Release

Simulations Plus Sets Date for 1st Quarter 2017 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Monday, January 9, 2017, at 4:15 PM ET

  • Read More
Simulations Plus Reports Record Preliminary Revenues for First Quarter FY2017
  • December 8, 2016
  • Press Release

Simulations Plus Reports Record Preliminary Revenues for First Quarter FY2017

Keywords: preliminary revenues
Division: PBPK
  • Read More
Simulations Plus Reports FY2016 and Fourth Quarter FY2016 Financial Results
  • November 11, 2016
  • Press Release

Simulations Plus Reports FY2016 and Fourth Quarter FY2016 Financial Results

Keywords: financial results, gross profit, net revenues
Division: PBPK

Full Fiscal Year Pharmaceutical Software and Services Up 9.1%;
Earnings per share $0.29, up 27.5% over prior year

  • Read More
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2016 Earnings Release and Conference Call
  • November 8, 2016
  • Press Release

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2016 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Friday, November 11, at 4:15 PM ET

  • Read More
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
  • October 31, 2016
  • Press Release

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share

Keywords: quarterly cash dividend
Division: PBPK
  • Read More
Simulations Plus Joins European SimInhale Consortium
  • September 26, 2016
  • Press Release

Simulations Plus Joins European SimInhale Consortium

Keywords: European Cooperation in Science and Technology, formulation design, inhaled medicines, lung tissue, particle aerosolization, pulmonary model, pulmonary playlist, SimInhale, toxicity analysis
Division: PBPK

EU Framework Programme (Horizon 2020) for Acceleration of New Inhaled Medicines

  • Read More
Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2016
  • September 12, 2016
  • Press Release

Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2016

Keywords: preliminary revenues
Division: PBPK

Company Reports Record Fourth-Quarter and Full-Year Revenues

  • Read More
Simulations Plus Releases PKPlus™ Version 1.0
  • August 25, 2016
  • Press Release

Simulations Plus Releases PKPlus™ Version 1.0

Keywords: analysis of preclinical and clinical trial data, audit trail and validation, compartmental analysis (CA), nca, noncompartmental analysis (NCA), PK modeling platform, U.S. FDA, validated PK software
Software: PKPlus™
Division: PBPK

Next-generation software for preclinical and clinical trial data analysis

  • Read More
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
  • August 1, 2016
  • Press Release

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share

Keywords: quarterly cash dividend
Division: PBPK
  • Read More
Simulations Plus Releases ADMET Predictor™ Version 8.0
  • August 1, 2016
  • Press Release

Simulations Plus Releases ADMET Predictor™ Version 8.0

Keywords: adme predictions, drug discovery, molecular property prediction software
Software: ADMET Predictor®
Division: PBPK

Major upgrade includes fresh interface, additional capabilities

  • Read More
Simulations Plus Reports Third Quarter FY2016 Financial Results
  • July 14, 2016
  • Press Release

Simulations Plus Reports Third Quarter FY2016 Financial Results

Keywords: quarterly cash dividend
Division: PBPK

Record quarterly revenue, 9moFY16 diluted EPS increased 23% to a record $0.242 from $0.196

  • Read More
Simulations Plus Sets Date for 3rd Quarter 2016 Earnings Release and Conference Call
  • July 8, 2016
  • Press Release

Simulations Plus Sets Date for 3rd Quarter 2016 Earnings Release and Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Thursday, July 14, at 4:15 PM ET

  • Read More
Simulations Plus Reports Preliminary Revenues for Third Quarter FY2016
  • June 7, 2016
  • Press Release

Simulations Plus Reports Preliminary Revenues for Third Quarter FY2016

Keywords: preliminary revenues
Division: PBPK
  • Read More
Simulations Plus to Present at LD Micro Invitational on June 7, 2016
  • June 2, 2016
  • Press Release

Simulations Plus to Present at LD Micro Invitational on June 7, 2016

Keywords: investor relations, LD Micro Invitational
  • Read More
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
  • April 22, 2016
  • Press Release

Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share

Keywords: quarterly cash dividend
Division: PBPK
  • Read More
Simulations Plus Releases DDDPlus Version 5.0
  • April 14, 2016
  • Press Release

Simulations Plus Releases DDDPlus Version 5.0

Keywords: in vitro dissolution experiment simulation software, pharmaceutical dosage forms
Software: DDDPlus™
Division: PBPK

Release adds significant enhancements to unique software product

  • Read More
  • «
  • 1
  • 2
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 27
  • 28
  • »
Ready to get started?

Sign-up for a free evaluation or schedule a meeting with one of our experts!

Questions? Email info@simulations-plus.com

Discuss my project needs with an expert
Schedule a software demo
Join our newsletter
Software
  • GastroPlus®
  • MonolixSuite™
  • ADMET Predictor®
  • DILIsym®
  • DDDPlus™
  • NAFLDsym®
  • MembranePlus™
  • OBESITYsym™
  • PKanalix®
  • Simulx®
  • IPFsym®
  • ILDsym®
  • MITOsym®
  • QSP Software
  • Pro-ficiency
  • Panorama KOL Insights Engine
  • MedChem Designer™
Services
  • Early Drug Discovery
  • Physiologically Based Pharmacokinetics (PBPK)
  • Quantitative Systems Pharmacology (QSP)
  • Clinical Pharmacology & Pharmacometrics (CPP)
  • Adaptive Learning & Insights (ALI)
  • Medical Communications Services
  • Concierge
  • Training and Workshops
Resource Center
  • Blog
  • Journal Articles
  • Flyers
  • Posters
  • Presentations
  • Press Releases
  • Videos
  • White Papers
  • Webinars
Investors
  • Board of Directors
  • Environmental, Social and Governance (ESG)
  • Latest Presentations
  • Press Releases
  • SEC Filings
  • Shareholder Information
  • Corporate Development Initiative
About
  • Simulations Plus
  • Contact
  • Careers
  • Leadership
  • Partners and Collaborators
  • Privacy Notice
  • Cookie Notice
  • Vision, Mission & Values
  • FCOI Policy
Support
  • Customer Portal
  • Datasheets
  • Software Installation
  • Contact Support
Simulations Plus
  • GastroPlus
  • Copyright © 2025 Simulations Plus. All Rights Reserved.
    • Privacy Notice
    • Sitemap
    • Terms of Use
    • Cookie Settings
This website uses cookies
We use cookies to enhance your browsing experience and analyze our traffic. To learn more about our use of cookies and other tracking technologies, please see our Cookie Notice and our Privacy Notice. By clicking “Accept All,” you consent to such use by us of cookies and other tracking technologies. To learn more about your privacy rights and our personal data practices, please see our Privacy Notice.
Accept All Reject AllCookie Settings
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. For more information on use of cookies or similar tracking technologies on our website: View our Cookie Notice. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept